你即將離開本站

並前往https://academic.oup.com/eurpub/article/28/suppl_4/cky218.153/5191842

Budget Impact Model of riociguat (Adempas®) in Pulmonary ...

Riociguat (Adempas®) is a new oral drug, belonging to the soluble guanylate cyclase stimulator class, indicated for PAH.

確定！ 回上一頁

查詢 「Riociguat」的人也找了：

  1. riociguat中文
    2.
  2. riociguat健保
    3.
  3. riociguat仿單
    4.
  4. Treprostinil
    5.
  5. Iloprost
    6.
  6. 肺動脈 高壓治療指引
    7.
  7. Riociguat mechanism
    8.
  8. Sildenafil
    9.